María-Teresa Cedena (Maria Teresa Cedena, María T Cedena, M Teresa Cedena, Teresa Cedena, María Teresa Cedena, Maria-Teresa Cedena, Maria Teresa Cedena Romero)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Multiple Myeloma

Machine Learning

Prognostic Factors

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of haematology

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Noemi Puig, Cristina Agullo Roca, Teresa Contreras Sanfeliciano, María-Teresa Cedena, Joaquín Martínez-López, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Belén Iñigo Rodríguez, Anna Sureda, Sunil Lakhwani, Javier de la Rubia Comos, Verónica González De La Calle, Valentín Cabañas, Luis Palomera, José María M Moraleda, Joan Bargay, Sergio Castro, Laura Rosinol, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Juan José Lahuerta, Maria-Victoria Mateos-Manteca
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma. Blood (2024)
Adrián Mosquera Orgueira, Manuel Mateo Perez Encinas, Nicolas Diaz Varela, Yu-Hung Wang, Elvira Mora, Marina Díaz-Beyá, Maria Julia Montoro, Helena Pomares Marin, Fernando Ramos, Mar Tormo, Andrés Jerez, Josep Nomdedeu, Carlos De Miguel Sánchez, Leonor Arenillas, Paula Carcel, María-Teresa Cedena, Blanca Xicoy Cirici, Eugenia Rivero Arango, Rafael Andrés Del Orbe Barreto, Luis Benlloch, Chien-Chin Lin, Hwei-Fang Tien, Carlos Pérez Míguez, Davide Crucitti, Maria Diez Campelo, David Valcárcel
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. British journal of haematology 204 (4) (2024)
Adrián Mosquera Orgueira, Manuel Mateo Perez Encinas, Nicolas Diaz Varela, Yu-Hung Wang, Elvira Mora, Marina Díaz-Beyá, Maria Julia Montoro, Helena Pomares Marin, Fernando Ramos, Mar Tormo, Andrés Jerez, Josep Nomdedeu, Carlos De Miguel Sánchez, Leonor Arenillas, Paula Carcel, María-Teresa Cedena, Blanca Xicoy Cirici, Eugenia Rivero Arango, Rafael Andrés Del Orbe Barreto, Luis Benlloch, Chien-Chin Lin, Hwei-Fang Tien, Carlos Pérez Míguez, Davide Crucitti, Maria Diez Campelo, David Valcárcel
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. British journal of haematology (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Paula Rodriguez Otero, Verónica González-Calle, Marta Sonia Gonzalez, Albert Ortiol, Norma C Gutiérrez, Rafael Rios-Tamayo, Laura Rosinol, Miguel Angel Alvarez Rivas, Joan Bargay, Ana Pilar Gonzalez-Rodriguez, Adrian Alegre, Fernando Escalante, María Belén Iñigo Rodríguez, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, Marta Reinoso-Segura, Aránzazu García Mateo, Enrique María Ocio, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, null null
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Adrián Mosquera Orgueira, Manuel Mateo Perez Encinas, Nicolas Diaz Varela, Yu-Hung Wang, Elvira Mora, Marina Díaz-Beyá, Maria Julia Montoro, Helena Pomares Marin, Fernando Ramos, Mar Tormo, Andrés Jerez, Josep Nomdedeu, Carlos De Miguel Sánchez, Leonor Arenillas, Paula Carcel, María-Teresa Cedena, Blanca Xicoy Cirici, Eugenia Rivero Arango, Rafael Andrés Del Orbe Barreto, Luis Benlloch, Chien-Chin Lin, Hwei-Fang Tien, Carlos Pérez Míguez, Davide Crucitti, Maria Diez Campelo, David Valcárcel
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. British journal of haematology 204 (4) (2024)
Cirino Botta, Cristina Perez, Marta Larrayoz, Noemi Puig, María-Teresa Cedena, Rosalinda Termini, Ibai Goicoechea, Sara Rodriguez, Aintzane Zabaleta, Aitziber Lopez, Sarai Sarvide, Laura Blanco, Daniele M Papetti, Marco Salvatore Nobile, Daniela Besozzi, Massimo Gentile, Pierpaolo Correale, Sergio Siragusa, Albert Oriol, Maria Esther González-Garcia, Anna Sureda, Felipe de Arriba, Rafael Rios-Tamayo, José María M Moraleda, Mercedes Gironella, Miguel T Hernandez, Joan Bargay, Luis Palomera, Albert Pérez-Montaña, Hartmut Goldschmidt, Hervé Avet-Loiseau, Aldo M Roccaro, Alberto Orfao, Joaquin Martinez-Lopez, Laura Rosinol, Juan-José Lahuerta, Joan Bladé, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Jose-Angel Martinez-Climent, Juan José Lahuerta, null null, null null
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nature communications 14 (1) (2023)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, María-José Calasanz, Norma C Gutiérrez, Manuela Fernandez, Albert Ortiol, Rafael Rios-Tamayo, Miguel-Teodoro T Hernandez Garcia, Rafael Martínez-Martínez, Joan Bargay, Felipe de Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Marta-Sonia Gonzalez Perez, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Laura Rosinol, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Juan José Lahuerta
Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients. Blood (2023)
Irene Zamanillo, Lucia Medina de Alba, Rodrigo Gil, Rosalia de la Puerta, Rafael Alonso, Ana Jimenez-Ubieto, María-Teresa Cedena, Maria Calbacho, Rosa María Ayala, Joaquin Martinez Lopez
Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure. Life (Basel, Switzerland) 13 (9) (2023)
Leire Burgos, Luis Esteban Tamariz-Amador, Noemi Puig, María-Teresa Cedena, Camilla Guerrero, Tomas Jelinek, Sarah Johnson, Paolo Milani, Lourdes Cordon, Jose J Perez, Marta Lasa, Rosalinda Termini, Albert Ortiol, Miguel-Teodoro T Hernandez Garcia, Luis Palomera, Rafael Martinez-Martinez, Javier de la Rubia, Felipe de Arriba, Rafael Rios-Tamayo, Maria-Esther Gonzalez, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Isabel Krsnik, Albert Perez-Montaña, Verónica González De La Calle, Paula Rodriguez Otero, Vladimir Maisnar, Roman Hájek, Frits Van Rhee, Victor Jimenez-Zepeda, Giovanni Palladini, Giampaolo Merlini, Alberto Orfao, Javier de la Cruz, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, null null
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Noemí Puig, María-Teresa Contreras, Cristina Agulló, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín, María-Belén Iñigo, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Verónica González De La Calle, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María M Moraleda, Joan Bargay, María-Teresa Cedena, Juan José Lahuerta, Laura Rosiñol, Joan Bladé, Jesús San F Miguel, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma. Blood advances 6 (11) (2022)
Juan-José Garcés, María-Teresa Cedena, Noemi Puig, Leire Burgos, Jose J Perez, Lourdes Cordon, Juan A Flores-Montero, Luzalba Sanoja-Flores, María-José Calasanz, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín-Sánchez, Rafael Martínez-Martinez, Joan Bargay, Anna Sureda, Javier de la Rubia, Miguel-Teodoro T Hernandez Garcia, Paula Rodriguez Otero, Javier de la Cruz, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan José Lahuerta
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Tomas Jelinek, Renata Bezděková, David Zihala, Tereza Ševčíková, Anjana Anilkumar Sithara, Lenka Pospisilova, Sabina Sevcikova, Petra Polackova, Martin Stork, Zdenka Knechtova, Ondrej Venglar, Veronika Kapustová, Tereza Popkova, Ludmila Muronova, Zuzana Chyra, Matous Hrdinka, Michal Simicek, Juan-José Garcés, Noemi Puig, María-Teresa Cedena, Artur Jurczyszyn, Jorge J Castillo, Miroslav Penka, Jakub Radocha, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, Ludek Pour, Lucie Říhová, Roman Hájek
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, Ibai Goicoechea, Cristina Perez, Juan-José Garcés, Cirino Botta, María-José Calasanz, Norma C Gutierrez, Maria-Luisa Martin-Ramos, Albert Oriol, Rafael Rios-Tamayo, Miguel-Teodoro Hernandez, Rafael Martinez-Martinez, Joan Bargay, Felipe De Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Adrian Mosquera-Orgueira, Marta-Sonia Gonzalez-Perez, Joaquin Martinez-Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos, Jesus F San-Miguel, Bruno Paiva
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Noemí Puig, Juan A Flores-Montero, Leire Burgos, María-Teresa Cedena, Lourdes Cordón, José-Juan Pérez, Luzalba Sanoja-Flores, Irene Manrique, Paula Rodríguez-Otero, Laura Rosiñol, Joaquin Martinez Lopez, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Alberto Orfao, Juan José Lahuerta
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma. Cancers 13 (19) (2021)
Ana Jiménez-Ubieto, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Ríos, Jesús Martin, Rafael Martínez, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María Sánchez-Pina, Joan Bargay, Maria-Victoria Mateos-Manteca, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan-José Lahuerta, null null
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change? Blood 138 (19) (2021)
María-Teresa Cedena, Estela Martin-Clavero, Sandy Wong, Nina Shah, Natasha Bahri, Rafael Alonso, Carmen Barcenas, Antonio Valeri, Johny Salazar Tabares, Jose Sanchez-Pina, Clara Cuellar, Thomas Martin, Jeffrey Wolf, Juan-Jose Lahuerta, Joaquin Martinez-Lopez
The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements. PloS one 15 (8) (2020)
Laura Palomo, Mariam Ibáñez, María Abáigar, Iria Vázquez, Sara Álvarez, Marta Cabezón, Bárbara Tazón-Vega, Inmaculada Rapado, Francisco Fuster-Tormo, José Cervera, Rocío Benito, María J Larrayoz, Juan C Cigudosa, Lurdes Zamora, David Valcárcel, María-Teresa Cedena, Pamela Acha, Jesús M Hernández-Sánchez, Marta Fernández-Mercado, Guillermo Sanz, Jesús M Hernández-Rivas, María J Calasanz, Francesc Solé, Esperanza Such, null null
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia. British journal of haematology 188 (5) (2019)
Rafael Alonso Fernández, María-Teresa Cedena, Adolfo Gómez-Grande, Rafael Ríos, José María Moraleda, Valentín Cabañas, María José Moreno, Javier López-Jiménez, Fernando Martín, Alejandro Sanz, Antonio Valeri, Ana Jiménez, Ricardo Sanchez, Juan José Lahuerta, Joaquin Martinez-Lopez
Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma. American journal of hematology 94 (8) (2019)
Alba Rodríguez-García, Maria Luz Morales, Vanesa Garrido-García, Irene García-Baquero, Alejandra Leivas, Gonzalo Carreño-Tarragona, Ricardo Sanchez, Alicia Arenas, María-Teresa Cedena, Rosa María Ayala, José M Bautista, Joaquín Martínez-López, María Linares
Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy. Antioxidants (Basel, Switzerland) 8 (11) (2019)
Juan-José Lahuerta, Ana Jiménez-Ubieto, Bruno Paiva, Joaquin Martinez Lopez, José González-Medina, Lucía López-Anglada, María-Teresa Cedena, Noemi Puig, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martin, Rafael Martínez, Anna Sureda, Miguel Teodoro Hernández, Javier de la Rubia, Isabel Krsnik, Valentín Cabañas, Luis Palomera, Joan Bargay, María-Victoria Mateos, Laura Rosiñol, Jesús San F Miguel, Joan Blade
Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease. Blood 133 (25) (2019)
Maria Diez Campelo, Jose I Lorenzo, Raphael Itzykson, Silvia M Rojas, Céline Berthon, Elisa Luño, Odile Beyne-Rauzy, Jaime Perez-Oteyza, Norbert Vey, Joan Bargay, Sophie Park, María-Teresa Cedena, Dominique Bordessoule, Juan A Muñoz, Emmanuel Gyan, Esperanza Such, Sorin Visanica, Félix López-Cadenas, Stéphane de Botton, Jesús M Hernández-Rivas, Shanti Ame, Aspasia Stamatoullas, Jacques Delaunay, Celia Salanoubat, Françoise Isnard, Romain Guieze, Joan Pérez Guallar, Llorenc Badiella, Guillermo Sanz, Consuelo Cañizo, Pierre Fenaux
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries. British journal of haematology 181 (3) (2018)